FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

7 results

evkeeza
(evinacumab)
Regeneron Pharmaceuticals, Inc.
Usage: EVKEEZA is indicated as an adjunct therapy for adult and pediatric patients aged 5 years and older with homozygous familial hypercholesterolemia (HoFH). Its safety and effectiveness in other types of hypercholesterolemia, such as heterozygous familial hypercholesterolemia, have not been established.
eylea
(aflibercept)
Regeneron Pharmaceuticals, Inc.
Usage: EYLEA is indicated for treating neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and retinopathy of prematurity.
inmazeb
(atoltivimab, maftivimab, and odesivimab-ebgn)
Regeneron Pharmaceuticals, Inc.
Usage: INMAZEB is indicated for treating infections caused by *Orthoebolavirus zairense* in adults and pediatric patients, including neonates born to RT-PCR positive mothers. Its efficacy against other *Orthoebolavirus* species and *Orthomarburgvirus* has not been established. Consider drug susceptibility patterns when using INMAZEB.
libtayo
(cemiplimab-rwlc)
Regeneron Pharmaceuticals, Inc.
Usage: LIBTAYO is indicated for treating metastatic or locally advanced cutaneous squamous cell carcinoma in patients unfit for curative surgery/radiation, locally advanced/metastatic basal cell carcinoma following previous hedgehog inhibitor treatment, and for first-line treatment of non-small cell lung cancer in specific adult patients.
lynozyfic - linvoseltamab - gcpt injection, solution, concentrate
(Linvoseltamab-Gcpt)
Regeneron Pharmaceuticals, Inc.
praluent
(alirocumab)
Regeneron Pharmaceuticals, Inc.
Usage: PRALUENT® is indicated to reduce the risk of myocardial infarction, stroke, and unstable angina in adults with cardiovascular disease. It also lowers LDL-C in adults with primary hyperlipidemia or familial hypercholesterolemia and in pediatric patients aged 8 and older with heterozygous familial hypercholesterolemia.
veopoz
(Pozelimab)
Regeneron Pharmaceuticals, Inc.
Usage: VEOPOZ is indicated for treating adult and pediatric patients aged 1 year and older with CD55-deficient protein-losing enteropathy (PLE), also referred to as CHAPLE disease.

Regeneron Pharmaceuticals, Inc. drugs

evkeeza

eylea

inmazeb

libtayo

lynozyfic - linvoseltamab - gcpt injection, solution, concentrate

praluent

veopoz